Indivior PLC reported a delay in FDA approval for label changes on SUBLOCADE, communicated on February 12, 2025, which could impact their market strategy and product rollout.
AI Assistant
INDIVIOR PHARMACEUTICALS INC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.